Eastern Mediterranean University
Famagusta, 99450, Cyprus
Location status: Recruiting
Location contact
Mehtap Malkoç, Proffesor
CONTACT
Yaşam Direl, MSc
CONTACT
NCT Number: NCT06973980
It is aimed to investigate the responses of Fatty Acid Binding Protein 4 (FABP4), which has been discovered as a novel biomarker of obesity and metabolic diseases, to regular exercise training.
The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.
Interested in participating?
Request Info20 year–35 year
All sexes
Interventional
Not applicable
Famagusta, 99450, Cyprus
Location status: Recruiting
Mehtap Malkoç, Proffesor
CONTACT
Yaşam Direl, MSc
CONTACT
Fatty acid binding proteins are intracellular proteins involved in the transport of fatty acids and are particularly associated with lipolytic activity. These proteins constitute a group of molecules that regulate intracellular lipid responses and are linked to metabolic and inflammatory pathways.
Studies have shown that FABP4 is associated with hypertension, insulin resistance, obesity, and stroke.
Inhibition of FABP4 synthesis has emerged as a promising strategy for the treatment of obesity-related conditions, particularly insulin resistance and diabetes, and it is emphasized that exercise models to suppress FABP4 should be further investigated.
The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.
Hypotheses:
H01: HIIT has no effect on cardiometabolic risk factors in sedentary obese adults.
H02: HIIT has no effect on body composition in sedentary obese adults. H03: HIIT has no effect on plasma FABP4 levels in sedentary obese adults.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The exercises will be applied only to the intervention group for 12 weeks and will be progressively intensified every 4 weeks.
Time frame: Baseline, week 6 and week 12
The Human FABP4 (Fatty Acid Binding Protein 4, Adipocyte) ELISA Kit/96T/Feiyuebio will be used to evaluate fatty acid-binding proteins in the biological samples collected from the participants.
Time frame: Baseline, week 6 and week 12
used to evaluate overall health and detect a wide range of disorders, including anemia, infection, and many other diseases.
Time frame: Baseline, week 6 and week 12
used to measure the average blood glucose levels over the past 2 to 3 months; commonly used in the diagnosis and management of diabetes.
Time frame: Baseline, week 6 and week 12
sed to measure the proportion of red blood cells in the blood; helps evaluate conditions such as anemia, dehydration, and other blood disorders.
Time frame: Baseline, week 6 and week 12
used to measure the level of "bad" cholesterol in the blood; high levels are associated with an increased risk of cardiovascular disease.
Time frame: Baseline, week 6 and week 12
Used to quantify the concentration of high-density lipoprotein (HDL) cholesterol in the bloodstream; elevated levels of HDL are inversely correlated with the risk of cardiovascular diseases, suggesting a protective effect on heart health.
Time frame: Baseline, week 6 and week 12
used to measure the concentration of triglycerides (a type of fat) in the blood; elevated levels are associated with an increased risk of cardiovascular disease, metabolic syndrome, and other health conditions.
Time frame: Baseline, week 6 and week 12
used to measure the concentration of glucose in the blood after an overnight fast; elevated levels may indicate impaired glucose metabolism or diabetes mellitus.
Time frame: Baseline, week 6 and week 12
used to measure the overall concentration of cholesterol in the blood, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very-low-density lipoprotein (VLDL); elevated levels are associated with an increased risk of cardiovascular diseases.
Time frame: Baseline, week 6 and week 12
The International Physical Activity Questionnaire Short Form will be used. A validity and reliability study has been conducted in Turkish, with test-retest reliability determined to be r=0.69. This form is self-administered and consists of seven questions assessing physical activity levels over the 'last seven days.' It provides information on time spent sitting, walking, engaging in moderate-intensity activities, and vigorous-intensity activities. The score is calculated by multiplying the minutes, days, and MET values. For calculations, 8 MET is used for vigorous physical activity, 4 MET for moderate-intensity activity, and 3.3 MET for walking. Since the scale is openly accessible, no usage permission is required.
Time frame: Baseline, week 6 and week 12
Time frame: Baseline, week 6 and week 12
The Bruce Treadmill Test protocol will be used to determine aerobic capacity and exercise intensity. Developed by Robert A. Bruce, the Bruce Treadmill Test protocol is widely used today for non-invasive estimation of VO2max. The incline and speed are regularly increased to reach the maximum level that an individual can achieve. The test consists of 9 stages. Prior to the test, participants will receive the necessary information, and their resting blood pressure, heart rate, and oxygen saturation will be measured. At the end of each stage, an ECG measurement will be taken in addition to these measurements, and at the end of the test, all measurements will be repeated. The peak heart rate obtained at the end of the test will be considered the maximal heart rate. Additionally, the peak heart rate obtained will be used to determine the intensity of the exercise protocols.
Time frame: Baseline, week 6 and week 12
Height (m) will be assessed by tape
Time frame: Baseline, week 6 and week 12
Body weight (kg) will be assessed using a Body Fat Analyzer.
Time frame: Baseline, week 6 and week 12
body mass indeks (kg/m²) will be calculated
Contact information is provided by the study sponsor or research team.
Mehtap MALKOÇ, Professor.
CONTACT
YAŞAM DİREL, MSc
CONTACT
Eastern Mediterranean University
Other
The Effect of High-Intensity Interval Training on Cardiometabolic Risk Factors, Body Composition, and Plasma FABP4 Levels in Sedentary Obese Adults.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07215533
Behavior, Body Weight
Syracuse, New York, United States
View Trial DetailsNCT05838950
Body Weight, Cardiovascular Diseases
Syracuse, New York, United States
View Trial DetailsNCT06851988
Aging, Behavior
New Taipei City, Taiwan
View Trial DetailsNCT07578740
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ankara, Turkey (Türkiye)
View Trial Details